Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting

Current evidence on the safety of transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting shows well-documented risks. The evidence on efficacy is adequate to support the use of this procedure provided that standard arrangements are in place for clinical governance, consent and audit. Find out what standard arrangements mean on the NICE interventional procedures guidance page.

Patient selection should be carried out by a multidisciplinary team, which should include an interventional radiologist or a neuroradiologist, a vascular surgeon and a physician with a specialist interest in stroke.

This procedure should only be carried out by clinicians with specific training and expertise in the technique who regularly perform complex endovascular interventions.